Over the past decade, the revenue for hospitals generated by the federal 340B drug discount program, initially intended to serve low-income, uninsured populations, has exploded even while a number of important Massachusetts hospitals have reduced the level of charity care they provide, according to a new study published by Pioneer Institute. The Pioneer Institute study, “340B Drug Discounts: An Increasingly Dysfunctional Program,” notes that nationwide, 340B drug sales rose from $9 billion in 2014 to $38 billion in 2020.
https://pioneerinstitute.org/wp-content/uploads/340-web-post.png9001600Editorial Staffhttps://pioneerinstitute.org/wp-content/uploads/logo_440x96.pngEditorial Staff2022-03-22 05:41:312022-03-25 14:38:00Massachusetts Hospitals Pull Back on Charity Care as Revenue from Federal 340B Drug Discount Program Explodes
https://pioneerinstitute.org/wp-content/uploads/MBTA-Subway-Returns-Feature.jpg
450
600
Eamon McCarthy Earls
https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png
Eamon McCarthy Earls2019-04-01 16:48:532021-10-29 15:18:12MBTAAnalysis: A look inside the MBTA
https://pioneerinstitute.org/wp-content/uploads/CloseupClock-1.jpg
739
1244
Mary Connaughton
https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png
Mary Connaughton2017-02-20 12:34:192017-02-21 09:47:58The Clock is Ticking…….
https://pioneerinstitute.org/wp-content/uploads/340-web-post.png
900
1600
Editorial Staff
https://pioneerinstitute.org/wp-content/uploads/logo_440x96.png
Editorial Staff2022-03-22 05:41:312022-03-25 14:38:00Massachusetts Hospitals Pull Back on Charity Care as Revenue from Federal 340B Drug Discount Program Explodes